Numerous paradoxical reactions have arisen during targeted therapy for psoriasis and atopic dermatitis, including the emergence of anti-nuclear antibodies (ANAs) and anti-dsDNA antibodies caused by TNF-α inhibitors in certain patients, resulting in autoimmunity. The gene discussed is TNF; the disease is psoriasis.